| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.923.181 | 7.947.193 | 9.093.453 | 9.579.571 | 9.885.679 | 10.085.802 | 11.347.461 | 13.784.834 | 15.855.656 | 16.629.400 |
| Total Income - EUR | 6.947.519 | 8.029.786 | 9.140.914 | 9.648.453 | 9.970.135 | 10.199.677 | 11.516.869 | 13.993.721 | 16.050.321 | 16.780.353 |
| Total Expenses - EUR | 6.708.937 | 7.690.022 | 8.877.204 | 9.349.851 | 9.653.436 | 9.679.392 | 11.033.962 | 13.475.631 | 15.589.526 | 16.388.032 |
| Gross Profit/Loss - EUR | 238.581 | 339.764 | 263.710 | 298.602 | 316.699 | 520.285 | 482.907 | 518.090 | 460.795 | 392.322 |
| Net Profit/Loss - EUR | 200.410 | 279.291 | 182.885 | 239.701 | 261.709 | 461.975 | 429.400 | 441.763 | 395.720 | 320.929 |
| Employees | 72 | 90 | 98 | 97 | 95 | 96 | 109 | 139 | 142 | 161 |
Check the financial reports for the company - Nicovid Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 796.390 | 1.042.066 | 1.104.388 | 1.169.760 | 1.127.451 | 1.300.376 | 1.647.083 | 2.065.507 | 2.741.616 | 3.322.802 |
| Current Assets | 1.296.122 | 1.419.678 | 1.465.512 | 1.406.225 | 1.453.686 | 1.519.711 | 1.887.153 | 2.004.000 | 2.289.493 | 2.819.262 |
| Inventories | 862.735 | 965.600 | 1.017.558 | 1.013.568 | 1.097.410 | 1.214.219 | 1.452.273 | 1.635.647 | 1.966.163 | 2.504.382 |
| Receivables | 395.221 | 320.211 | 319.465 | 301.571 | 230.849 | 145.600 | 193.759 | 202.032 | 162.167 | 199.416 |
| Cash | 38.166 | 78.475 | 76.934 | 45.290 | 80.502 | 145.157 | 228.726 | 153.938 | 146.468 | 98.940 |
| Shareholders Funds | 734.477 | 908.206 | 945.990 | 992.620 | 710.514 | 994.175 | 1.236.141 | 1.373.122 | 1.567.898 | 1.485.115 |
| Social Capital | 22.542 | 22.312 | 21.935 | 21.532 | 21.115 | 20.715 | 20.256 | 20.318 | 20.257 | 20.144 |
| Debts | 1.369.090 | 1.563.449 | 1.630.170 | 1.587.961 | 1.882.255 | 1.780.495 | 2.243.094 | 2.646.055 | 3.398.436 | 4.613.362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 5.685 | 4.401 | 6.235 | 4.220 | 2.211 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Nicovid Srl